Phreesia, Inc.
PHR

$1.46 B
Marketcap
$25.16
Share price
Country
$1.32
Change (1 day)
$29.16
Year High
$17.07
Year Low

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

marketcap

P/B ratio for Phreesia, Inc. (PHR)

P/B ratio as of 2024: 5.53

According to Phreesia, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.53. At the end of 2023 the company had a P/B ratio of 6.83.

P/B ratio history for Phreesia, Inc. from 2018 to 2024

P/B ratio at the end of each year

Year P/B ratio
2024 5.53
2023 6.83
2022 3.73
2021 10.02
2020 6.18
2019 -0.22
2018 -0.23